Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction

BACKGROUND: In thalassemia major (TM), severe cardiac siderosis can be treated by continuous parenteral deferoxamine, but poor compliance, complications and deaths occur. Combined chelation therapy with deferiprone and deferoxamine is effective for moderate myocardial siderosis, but has not been pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanner, Mark A, Galanello, Renzo, Dessi, Carlo, Smith, Gillian C, Westwood, Mark A, Agus, Annalisa, Pibiri, Martina, Nair, Sunil V, Walker, J Malcolm, Pennell, Dudley J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2289829/
https://www.ncbi.nlm.nih.gov/pubmed/18298856
http://dx.doi.org/10.1186/1532-429X-10-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2289829/
https://www.ncbi.nlm.nih.gov/pubmed/18298856
http://dx.doi.org/10.1186/1532-429X-10-12

Ejemplares similares